The generic drugs are defined as the medications which have the same active ingredient as that of branded drugs. They also yield the same therapeutic effect and are prescribed in the same dosing. The inactive ingredients are differ as compared to their branded counter parts. Generic drugs are mainly marketed after a patent expiry of the branded drug. These drugs are of equivalent quality as compared to the branded drugs & are manufactured under the same safety and manufacturing procedures.
Market DriversThe growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases etc., which expected to boost the global generic drugs market growth over the forecast period. The generic drugs are cheaper & equivalent to barded drugs in strength, dosage, route of administration, performance, quality, and application. Also, the increase in geriatric population positively influence the global generic drugs market growth during this forecast period. Furthermore, the increase in healthcare expenditure expected to fuel the market growth. Moreover, huge demand for generic medicine as well as a large number of patents expired branded drugs will propel the global generic drugs market growth. In addition, the growing demand for newer versions of generic drugs, and large numbers of licensing & partnering strategies to launch new products by key vendors will support the market growth in near future.
Market Restraints
Stringent governmental regulations and adverse effects associated with drugs are anticipated to hamper the global generic drugs market during this forecast timeframe.
The Global generic Drugs Market is segmented into product type such as Simple Generics, Super Generics, and Biosimilars, by application such as Anti-infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Respiratory Products, Anti-Cancer Drugs, and Others. Further, market is segmented into distribution channel such as Pharmacies, Private Clinics, Drug Stores, Hospitals, Retail Pharmacies, and Others.
Also, the Global Generic Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Market Taxonomy
By Application
By Distribution Channel
By Region
Key Questions Addressed by the Report
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Generic Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Generic Drugs Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Generic Drugs Market Share Analysis, By Product Type
5.3 Global Generic Drugs Market Size and Forecast, By Product Type
5.3.1 Simple Generics
5.3.2 Super Generics
5.3.3 Biosimilars
6 Global Generic Drugs Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Generic Drugs Market Share Analysis, By Application
6.3 Global Generic Drugs Market Size and Forecast, By Application
6.3.1 Anti-infective Drugs
6.3.2 Anti-Arthritis Drugs
6.3.3 Central Nervous System Drugs
6.3.4 Respiratory Products
6.3.5 Anti-Cancer Drugs
6.3.6 Others
7 Global Generic Drugs Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Generic Drugs Market Share Analysis, By Distribution Channel
7.3 Global Generic Drugs Market Size and Forecast, By Distribution Channel
7.3. 1 Pharmacies
7.3.2 Private Clinics
7.3.3 Drug Stores
7.3.4 Hospitals
7.3.5 Retail Pharmacies
7.3.6 Others
8Global Generic Drugs Market, By Region
8.1 Global Generic Drugs Market Share Analysis, By Region
8.2 Global Generic Drugs Market Share Analysis, By Region
8.3 Global Generic Drugs Market Size and Forecast, By Region
9 North America Generic Drugs Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Generic Drugs Market Share Analysis, By Product Type
9.3 North America Generic Drugs Market Size and Forecast, By Application
9.4 North America Generic Drugs Market Size and Forecast, By Distribution Channel
9.5 North America Generic Drugs Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeGeneric Drugs Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Generic Drugs Market Share Analysis, By Product Type
10.3 Europe Generic Drugs Market Size and Forecast, By Application
10.4 Europe Generic Drugs Market Size and Forecast, By Distribution Channel
10.5 Europe Generic Drugs Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Generic Drugs Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Generic Drugs Market Share Analysis, By Product Type
11.3 Asia Pacific Generic Drugs Market Size and Forecast, By Application
11.4 Asia Pacific Generic Drugs Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Generic Drugs Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Generic Drugs Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Generic Drugs Market Share Analysis, By Product Type
12.3 Latin America Generic Drugs Market Size and Forecast, By Application
12.4 Latin America Generic Drugs Market Size and Forecast, By Distribution Channel
12.5 Latin America Generic Drugs Market Size and Forecast, Country
13Middle East Generic Drugs Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Generic Drugs Market Share Analysis, By Product Type
13.3 Middle East Generic Drugs Market Size and Forecast, By Application
13.4 Middle East Generic Drugs Market Size and Forecast, By Distribution Channel
13.5 Middle East Generic Drugs Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Abbott Laboratories
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. GlaxoSmithKline Plc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Eli Lilly and Company
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Pfizer Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 STADA Arzneimittel AG
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Teva Pharmaceutical
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Mylan N.V.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Sandoz International
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Baxter International
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10ALLERGAN
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
